David Dankort

5.1k total citations · 1 hit paper
39 papers, 3.9k citations indexed

About

David Dankort is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, David Dankort has authored 39 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 27 papers in Molecular Biology and 11 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in David Dankort's work include HER2/EGFR in Cancer Research (13 papers), Monoclonal and Polyclonal Antibodies Research (11 papers) and Melanoma and MAPK Pathways (9 papers). David Dankort is often cited by papers focused on HER2/EGFR in Cancer Research (13 papers), Monoclonal and Polyclonal Antibodies Research (11 papers) and Melanoma and MAPK Pathways (9 papers). David Dankort collaborates with scholars based in Canada, United States and Australia. David Dankort's co-authors include William J. Muller, Martin McMahon, David P. Curley, Peter M. Siegel, Marcus Bosenberg, William Damsky, Anthony N. Karnezis, Betsy Nelson, Ronald A. DePinho and M. James You and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Genetics.

In The Last Decade

David Dankort

39 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

BrafV600E cooperates with Pten loss to induce metastatic melanoma

2009 835 citations David Dankort, David P. Curley et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Dankort Canada	25	2.6k	2.0k	581	567	449	39	3.9k
Michael Reedijk Canada	33	2.4k 0.9×	1.4k 0.7×	731 1.3×	634 1.1×	313 0.7×	50	3.7k
Chantale T. Guy Canada	12	2.1k 0.8×	2.0k 1.0×	681 1.2×	754 1.3×	263 0.6×	13	3.7k
Marina Holgado-Madruga United States	24	2.4k 0.9×	1.1k 0.5×	378 0.7×	534 0.9×	369 0.8×	33	3.3k
Motoo Nagane Japan	28	2.5k 0.9×	1.3k 0.7×	959 1.7×	448 0.8×	280 0.6×	113	4.3k
Seth A. Ettenberg United States	23	2.8k 1.1×	1.9k 1.0×	544 0.9×	1.0k 1.8×	348 0.8×	44	4.2k
Rachel B. Hazan United States	23	2.3k 0.9×	1.4k 0.7×	664 1.1×	230 0.4×	847 1.9×	30	3.6k
Robert Soriano United States	19	2.7k 1.0×	1.5k 0.8×	1.5k 2.5×	639 1.1×	303 0.7×	20	5.1k
Caterina Bianco United States	41	3.8k 1.4×	2.4k 1.2×	608 1.0×	308 0.5×	788 1.8×	76	5.4k
Hadassa Waterman Israel	10	2.7k 1.0×	1.9k 0.9×	258 0.4×	413 0.7×	827 1.8×	10	3.8k
Patrick W.B. Derksen Netherlands	36	3.2k 1.2×	2.4k 1.2×	926 1.6×	459 0.8×	765 1.7×	70	4.9k

Countries citing papers authored by David Dankort

Since Specialization

Citations

This map shows the geographic impact of David Dankort's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Dankort with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Dankort more than expected).

Fields of papers citing papers by David Dankort

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Dankort. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Dankort. The network helps show where David Dankort may publish in the future.

Co-authorship network of co-authors of David Dankort

This figure shows the co-authorship network connecting the top 25 collaborators of David Dankort. A scholar is included among the top collaborators of David Dankort based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Dankort. David Dankort is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ran, Shu, et al.. (2021). Metabolic Regulator IAPP (Amylin) Is Required for BRAF and RAS Oncogene-Induced Senescence. Molecular Cancer Research. 19(5). 874–885. 2 indexed citations

Shai, Anny, David Dankort, Joseph Juan, Shon Green, & Martin McMahon. (2015). TP53 Silencing Bypasses Growth Arrest of BRAFV600E-Induced Lung Tumor Cells in a Two-Switch Model of Lung Tumorigenesis. Cancer Research. 75(15). 3167–3180. 14 indexed citations

Damsky, William, Goran Micevic, Katrina Meeth, et al.. (2015). mTORC1 Activation Blocks BrafV600E-Induced Growth Arrest but Is Insufficient for Melanoma Formation. Cancer Cell. 27(1). 41–56. 87 indexed citations

Dankort, David, et al.. (2014). Ras Effector Mutant Expression Suggest a Negative Regulator Inhibits Lung Tumor Formation. PLoS ONE. 9(1). e84745–e84745. 21 indexed citations

Ramdzan, Zubaidah M., Charles Vadnais, Ranjana Pal, et al.. (2014). RAS Transformation Requires CUX1-Dependent Repair of Oxidative DNA Damage. PLoS Biology. 12(3). e1001807–e1001807. 53 indexed citations

Pinard, Maxime, et al.. (2014). The inhibitor of kappa B kinase-epsilon regulates MMP-3 expression levels and can promote lung metastasis. Oncogenesis. 3(8). e116–e116. 5 indexed citations

Kamata, Tamihiro, David Dankort, Jing‐Qiong Kang, et al.. (2013). Hematopoietic Expression of Oncogenic BRAF Promotes Aberrant Growth of Monocyte-Lineage Cells Resistant to PLX4720. Molecular Cancer Research. 11(12). 1530–1541. 6 indexed citations

Dankort, David, et al.. (2013). A Modular Lentiviral and Retroviral Construction System to Rapidly Generate Vectors for Gene Expression and Gene Knockdown In Vitro and In Vivo. PLoS ONE. 8(10). e76279–e76279. 11 indexed citations

Wang, Jingqiang, Takashi Kobayashi, Nicolas Floc’h, et al.. (2012). B-Raf Activation Cooperates with PTEN Loss to Drive c-Myc Expression in Advanced Prostate Cancer. Cancer Research. 72(18). 4765–4776. 78 indexed citations

10.

Collisson, Eric A., Christy L. Trejo, Jillian M. Silva, et al.. (2012). A Central Role for RAF→MEK→ERK Signaling in the Genesis of Pancreatic Ductal Adenocarcinoma. Cancer Discovery. 2(8). 685–693. 219 indexed citations

11.

Damsky, William, David P. Curley, Manjula Santhanakrishnan, et al.. (2011). β-Catenin Signaling Controls Metastasis in Braf-Activated Pten-Deficient Melanomas. Cancer Cell. 20(6). 741–754. 267 indexed citations

12.

Held, Matthew A., David P. Curley, David Dankort, et al.. (2010). Characterization of Melanoma Cells Capable of Propagating Tumors from a Single Cell. Cancer Research. 70(1). 388–397. 73 indexed citations

13.

Dankort, David, et al.. (2007). A new mouse model to explore the initiation, progression, and therapy of BRAF^V600E-induced lung tumors. Genes & Development. 21(4). 379–384. 373 indexed citations

14.

Chan, Richard, et al.. (2004). Modulation of Erbb2 signaling during development: a threshold level of Erbb2 signaling is required for development. Development. 131(22). 5551–5560. 13 indexed citations

15.

Marone, Romina, Daniel Heß, David Dankort, et al.. (2004). Memo mediates ErbB2-driven cell motility. Nature Cell Biology. 6(6). 515–522. 106 indexed citations

16.

Loureiro, Robyn, Arindel S.R. Maharaj, David Dankort, William J. Muller, & Patrìcia A. D'Amore. (2004). ErbB2 overexpression in mammary cells upregulates VEGF through the core promoter. Biochemical and Biophysical Research Communications. 326(2). 455–465. 23 indexed citations

17.

Khoury, Hanane, Monica A. Naujokas, Dongmei Zuo, et al.. (2004). HGF Converts ErbB2/Neu Epithelial Morphogenesis to Cell Invasion. Molecular Biology of the Cell. 16(2). 550–561. 94 indexed citations

18.

Khoury, Hanane, David Dankort, Svetlana Sadekova, et al.. (2001). Distinct tyrosine autophosphorylation sites mediate induction of epithelial mesenchymal like transition by an activated ErbB-2/Neu receptor. Oncogene. 20(7). 788–799. 50 indexed citations

19.

Dankort, David, Neil Warner, Harold Kim, et al.. (2001). Grb2 and Shc Adapter Proteins Play Distinct Roles in Neu (ErbB-2)-Induced Mammary Tumorigenesis: Implications for Human Breast Cancer. Molecular and Cellular Biology. 21(5). 1540–1551. 138 indexed citations

20.

Siegel, Peter M., David Dankort, W. Rod Hardy, & William J. Muller. (1994). Novel Activating Mutations in the neu Proto-oncogene Involved in Induction of Mammary Tumors. Molecular and Cellular Biology. 14(11). 7068–7077. 167 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact